Literature DB >> 15692790

Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease.

Yasumi Katsuta1, Hiroshi Honma, Xue-Jun Zhang, Masaru Ohsuga, Hirokazu Komeichi, Shuji Shimizu, Yoshihito Katoh, Hiroshi Miura, Katsuaki Satomura, Takumi Aramaki, Teruo Takano.   

Abstract

BACKGROUND: Contrast-enhanced echocardiography (CEE) using agitated saline can detect intrapulmonary vasodilatation (IPVD) in patients with hepatopulmonary syndrome (HPS). We estimated the pulmonary transit time of erythrocytes (PTT) by CEE, using microbubbles, and studied its relationship to arterial oxygenation in chronic liver disease.
METHODS: Sixteen patients with chronic liver disease and seven healthy subjects were studied. PTT was defined as the time between opacification of the right atrium and left atrium on CEE, using human serum albumin-air microbubble complexes with a mean diameter of 4 microm (Albunex). IPVD was detected by CEE with agitated saline. Arterial blood gases were analyzed with patients in the supine position, and while they were seated. Cardiac output (CO) was determined by Doppler echocardiography.
RESULTS: The mean PTT value for all of the patients was 4.0 +/- 1.4 s. One of the 3 patients who showed IPVD was normoxemic. Mild orthodeoxia was observed in the patients with abnormal alveolar-arterial oxygen difference (A-aDO2) values (>15 mmHg), but not in those with normal A-aDO2 values, or in the healthy subjects. PTT was correlated with PaO2 (r = 0.52; P < 0.05; n = 16) and A-aDO2 (r = -0.54; P < 0.05; n = 16) in the seated position. CO was significantly correlated with PTT (r = -0.62; P < 0.05; n = 15), but not with PaO2 and A-aDO2, in both positions.
CONCLUSIONS: PTT may be a useful parameter for evaluating arterial oxygenation in patients with chronic liver disease with early HPS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692790     DOI: 10.1007/s00535-004-1495-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  9 in total

Review 1.  Portopulmonary hypertension.

Authors:  Michael Halank; Ralf Ewert; Hans-Juergen Seyfarth; Gert Hoeffken
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

2.  Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension.

Authors:  Yasumi Katsuta; Xue-Jun Zhang; Masaru Ohsuga; Toshio Akimoto; Hirokazu Komeichi; Shuji Shimizu; Yoshihito Kato; Akiko Miyamoto; Katsuaki Satomura; Teruo Takano
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

Review 3.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

4.  Management of cardiopulmonary complications of cirrhosis.

Authors:  Prabha Sawant; C Vashishtha; M Nasa
Journal:  Int J Hepatol       Date:  2011-07-19

Review 5.  Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives.

Authors:  Yannis Dimitroglou; Constantina Aggeli; Alexandra Alexopoulou; Sophie Mavrogeni; Dimitris Tousoulis
Journal:  J Clin Med       Date:  2019-12-03       Impact factor: 4.241

Review 6.  Pulmonary manifestations of chronic liver disease: a comprehensive review.

Authors:  Stergios Soulaidopoulos; Ioannis Goulis; Evangelos Cholongitas
Journal:  Ann Gastroenterol       Date:  2020-03-27

Review 7.  Advances in Diagnostic Imaging of Hepatopulmonary Syndrome.

Authors:  Bi-Wei Luo; Zhi-Yong Du
Journal:  Front Med (Lausanne)       Date:  2022-01-10

8.  A case report of suspected hepatopulmonary syndrome secondary to ductal plate malformation with chronic active hepatitis in a dog.

Authors:  Yasuyuki Kaneko; Shidow Torisu; Mitsuyoshi Hagio; Ryoji Yamaguchi; Shinya Mizutani; Kiyokazu Naganobu
Journal:  J Vet Med Sci       Date:  2015-11-30       Impact factor: 1.267

Review 9.  Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature.

Authors:  Caglar Cosarderelioglu; Arif M Cosar; Merve Gurakar; Nabil N Dagher; Ahmet Gurakar
Journal:  J Clin Transl Hepatol       Date:  2016-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.